Meghan Burke

464 total citations
6 papers, 117 citations indexed

About

Meghan Burke is a scholar working on Hematology, Genetics and Cancer Research. According to data from OpenAlex, Meghan Burke has authored 6 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 2 papers in Cancer Research. Recurrent topics in Meghan Burke's work include Acute Myeloid Leukemia Research (4 papers), Cancer Genomics and Diagnostics (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Meghan Burke is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cancer Genomics and Diagnostics (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Meghan Burke collaborates with scholars based in United States. Meghan Burke's co-authors include Amir T. Fathi, Katharine Yen, Michaela J. Higgins, Sam Agresta, Hossein Sadrzadeh, Ashley Perry, Darrell R. Borger, Aditya Bardia, David P. Schenkein and Kimberly Straley and has published in prestigious journals such as Blood, The Oncologist and Blood Advances.

In The Last Decade

Meghan Burke

6 papers receiving 117 citations

Peers

Meghan Burke

MB

CR

HEMAT

GENET

RHEUM

Fabrizia Favale France

Sergiy Klymenko Ukraine

Chi Shan Kho China

Maria López‐Pavía Spain

Federico De Marchi United States

Bevan Tandon United States

Hélène Zattara France

K.-A. Kreuzer Germany

Hong L. Tiv United States

Desiree De Lange Netherlands

Fabrizia Favale France

Meghan Burke

43 ×0.8

MB

26 ×0.5

CR

82 ×2.2

HEMAT

43 ×1.5

GENET

21 ×0.8

RHEUM

Citations per year, relative to Meghan Burke Meghan Burke (= 1×) peers Fabrizia Favale

Countries citing papers authored by Meghan Burke

Since Specialization

Citations

This map shows the geographic impact of Meghan Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Burke more than expected).

Fields of papers citing papers by Meghan Burke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Burke. The network helps show where Meghan Burke may publish in the future.

Co-authorship network of co-authors of Meghan Burke

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan Burke. A scholar is included among the top collaborators of Meghan Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan Burke. Meghan Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Nardi, Valentina, Nora Ku, Matthew J. Frigault, et al.. (2020). Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement. Blood Advances. 4(1). 106–111. 22 indexed citations

2.

Kasbekar, Monica, Valentina Nardi, Paola Dal Cin, et al.. (2020). Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia. Blood Advances. 4(13). 3136–3140. 28 indexed citations

3.

Brunner, Andrew M., Donna Neuberg, Seth A. Wander, et al.. (2015). Use of 2HG Levels in the Serum, Urine, or Bone Marrow to Predict IDH Mutations in Adults with Acute Myeloid Leukemia. Blood. 126(23). 2597–2597. 4 indexed citations

4.

Fathi, Amir T., Hossein Sadrzadeh, Amy Comander, et al.. (2014). Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate. The Oncologist. 19(6). 602–607. 59 indexed citations

5.

Fathi, Amir T., Seth A. Wander, Traci M. Blonquist, et al.. (2014). A Phase I Study of the Aurora a Kinase Inhibitor Alisertib in Combination with 7+3 Induction Chemotherapy in Patients with Acute Myeloid Leukemia. Blood. 124(21). 119–119. 3 indexed citations

6.

Brunner, Andrew M., Seth A. Wander, Donna Neuberg, et al.. (2014). Diagnostic Features and 2-Hydroxyglutarate (2-HG) Levels Among Acute Myeloid Leukemia (AML) Patients with and without Isocitrate Dehydrogenase (IDH) Mutations. Blood. 124(21). 1045–1045. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact